染色体中基因复制数放大与 HER2 阳性转移性乳腺癌患者的异常反应相关
Charlotte Andrieu1, Jojanneke Stoof1, Dalal AlSultan1
1Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland.
Oncogene
|December 20, 2025
概括
对HER2阳性转移性乳腺癌 (MBC) 异常响应者的基因组分析揭示了放大的中心膜区域. 这些发现表明,在MBC患者中,延长缓解和存活的潜在机制.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
背景情况:
- 转移性乳腺癌 (MBC) 通常是无法治愈的.
- 一部分HER2阳性MBC患者经历了长期缓解,这引发了关于潜在治愈问题的疑问.
- 了解异常反应的基因组基础可能会揭示新的治疗点.
研究的目的:
- 为了研究 HER2 阳性 MBC 患者的基因组差异,这些患者获得了异常反应.
- 确定与长期缓解和存活相关的潜在生物标志物.
主要方法:
- 对27名患者进行全基因组测序和中粒体拷贝数 (CCN) 分析 (异常响应者,异常幸存者,短期响应者).
- 基因组比较分析专注于中心体区域.
- 数字PCR被用于验证特定的中心体区域.
主要成果:
- 异常响应者 (ExR) 与异常幸存者 (ExS) 和短期响应者 (STR) 相比,在中心区域显示显著放大.
- 中心体区域中较高的CCN与延长缓解和存活相关.
- 数字PCR验证没有将4号染色体的D4Z1副本数与ExR总生存率联系起来.
结论:
- 中心粒区域的放大与HER2阳性MBC患者的缓解和生存时间非常长.
- 中心放大可能是导致抗HER2疗法和化疗异常反应的关键机制.
- 对中心体变化的进一步研究可能会导致MBC的新治疗策略.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Centrosome Duplication
4.7K
The primary microtubule organizing center (MTOC) in animal cells is the centrosome. A centrosome has two cylindrical centrioles at its core. Each centriole consists of nine sets of three microtubules held together by proteins. The centrioles are positioned at right angles to each other and surrounded by a shapeless protein cloud called the pericentriolar matrix, or pericentriolar material (PCM).
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
4.7K


